Radiomed Corporation

Tyngsboro, MA 01879

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $1.71MM
First Award Date 09/30/97
Most Recent Award Date 09/14/01

Key Personnel

Last Name Name Awards Contact
Sioshansi Piran Sioshansi 9

9 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/14/01 - 02/28/02

Breast conserving therapy is by far the preferred choice of the majority of women with early stage breast carcinoma. The recommended options for radiation treatment following lumpectomy are external beam therapy and, in certain cases, an additional local dose by brachytherapy. Avoiding local occurrence is, naturally, the primary goal, but cosmes...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/04

Radiation is the most frequently used eye and vision-sparing alternative to enucleation of eyes with choroidal melanoma. Brachytherapy, in the form of ophthalmic (radioactive) plaques (OP) is a successful approach for treatment of choroidal melanoma. While preserving vision and minimizing complications, ophthalmic plaque radiotherapy has offered...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 08/31/03

Prostate cancer afflicts over 200,000 new patients, with a disproportionately large number of African-Americans, and causes 41,800 deaths(1) each year. Brachytherapy is an effective process for prostate cancer treatment,(2) and is being selected by a rapidly increasing proportion of patients. Current generation brachytherapy seeds consist either...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 08/31/01

Radiation is the most frequently used eye and vision-sparing alternative to enucleation of eyes with choroidal melanoma. Brachytherapy, in the form of ophthalmic (radioactive) plaques (OP) is a successful approach for treatment of choroidal melanoma. While preserving vision and minimizing complications, ophthalmic plaque radiotherapy has offered...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/99 - 08/31/00

Prostate cancer afflicts over 200,000 new patients, with a disproportionately large number of African-Americans, and causes 41,800 deaths(1) each year. Brachytherapy is an effective process for prostate cancer treatment,(2) and is being selected by a rapidly increasing proportion of patients. Current generation brachytherapy seeds consist either...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/99 - 06/30/99

DESCRIPTION: (Adapted from Applicant's Abstract) The overall goal of this proposal is to develop flexible brachytherapy patches to deliver focused radiation in a continuous hyperfractionated manner to the target lesion only and reduce the cost of the treatment significantly. Specifically, the applica...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/98 - 03/31/99

DESCRIPTION: This is a Phase I application to develop the fabrication technology of a brachytherapy source for the treatment of radiation- sensitive eye tumors that obviates some of the problems encountered with current systems. Brachytherapy, or contact therapy, is a treatment with ionizing radiation whos...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/04/98 - 08/31/98

DESCRIPTION: Brachytherapy, or interstitial radiation, is a successful approach for treatment of prostate cancer. In brachytherapy, a large number (50-100) of rice grain-sized seeds of Pd-103 or Iodine-125 are inserted into the prostate gland for delivering local radiation and eradicating cancerous c...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 06/30/98

Esophageal obstruction due to cancer can produce debilitating dysphagia. Rapid and safe palliation of dysphagia is usually possible with endoscopic implantation of expandable metal sent. A major complication of these prosthesis is occlusion due to tumor ingrowth or overgrowth. The curren...